Table 1.
Patient characteristics (n = 13)
| Patient demographics | |
| Gender, female | 12 |
| Age, years, mean ± SD | 51.2 ± 15.9, range 29–87 |
| BMI, kg/m2, mean ± SD | 29.4 ± 6.0 |
| ASA I/II/III/IV | 0/6/6/1 |
| Presenting symptoms | |
| Abdominal discomfort | 11 |
| Early satiety/nausea/vomiting | 5 |
| Weight loss | 2 |
| Asymptomatic | 1 |
| Physical exam findings | |
| None | 6 |
| Epigastric fullness/mass | 5 |
| Abdominal tenderness | 4 |
| Definitive imaging studya | |
| Ultrasound | 2 |
| MRI | 7 |
| CT | 3 |
| Imaging characteristics | |
| Maximal cyst diameter | 12.4 ± 4.6 cm, range 4.8–18.1 |
| Septations | 8 |
| Mural modules | 3 |
| Increasing in size | 4 |
| Reported as possible cystadenomab | 8 |
| Reported as possible cystadenocarcinomab | 2 |
| Cyst locationa | |
| Left hemiliver only | 5 |
| Central | 6 |
| Right hemiliver only | 1 |
a
Data are missing for one patient.
b
Interpretation as reported by abdominal/liver radiologists at the authors' institution.
ASA: American society of anesthesiologists score; BMI: body mass index; CT: computed tomography; MRI: magnetic resonance imaging; SD: standard deviation.